載入...
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
Na minha lista:
Main Authors: | , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BMC
2010-11-01
|
叢編: | Journal of Translational Medicine |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|